Generic Drug Approvals Still Winning The Pandemic At US FDA

 
• By Derrick Gingery

Productivity remains high as full ANDA approvals reached a FY 2020 peak and complete responses dropped to another low in June.

Generics
The FDA said several recent ANDA approvals came through its commitment to work past a goal date if approval was imminent. • Source: Shutterstock

More from User Fees

More from Pathways & Standards